Cytokine-armoured CAR T cells represent a new generation of programmable cell therapies designed to enhance efficacy while limiting toxicity. This Review explores how cytokine armouring and advances in synthetic receptor design and conditional gene circuits are reshaping immunotherapy for solid tumours.
- Krishneel Prasad
- Ryan S. Cross
- Misty R. Jenkins